Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Splenectomy in systemic lupus erythematosis.

J C Gruenberg, E J VanSlyck, J P Abraham

    The American Surgeon
    |July 1, 1986
    PubMed
    Summary

    Splenectomy can be a valuable treatment for select patients with systemic lupus erythematosus (SLE) experiencing autoimmune cytopenias. This surgery showed significant long-term benefits for thrombocytopenia, hemolytic anemia, and neutropenia in SLE cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pointing in a different direction: a case of bilateral absence of extensor indicis.

    Folia morphologica·2021
    Same author

    Application of an Intermittency Model for Laminar, Transitional, and Turbulent Internal Flows.

    Journal of fluids engineering·2021
    Same author

    Identification of a novel HLA-A*02 allele, HLA-A*02:01:01:32, in a deceased Caucasoid donor.

    HLA·2018
    Same author

    Impact of balloon inflation pressure on cell viability with single and multi lumen catheters.

    Journal of cardiovascular translational research·2014
    Same author

    Natural radioactivity content in soil and indoor air of Chellanam.

    Radiation protection dosimetry·2012
    Same author

    Isolated small gallbladder polyps: an indication for cholecystectomy in symptomatic patients.

    The American surgeon·2000

    Area of Science:

    • Rheumatology
    • Immunology
    • Surgical Pathology

    Background:

    • Systemic lupus erythematosus (SLE) is a complex autoimmune disease with diverse clinical manifestations.
    • Cytopenias, including thrombocytopenia, autoimmune hemolytic anemia, and neutropenia, can be challenging complications of SLE.
    • Refractory cytopenias in SLE often necessitate aggressive treatment strategies.

    Purpose of the Study:

    • To evaluate the efficacy and safety of splenectomy in patients with systemic lupus erythematosus (SLE).
    • To assess the long-term outcomes of splenectomy for cytopenias associated with SLE.
    • To determine if splenectomy impacts other aspects of SLE, such as renal function.

    Main Methods:

    • Retrospective analysis of 860 patients with SLE over a 25-year period.
    • Identification of patients who underwent splenectomy (16 patients, 1.9%).
    • Review of clinical outcomes, including response to splenectomy for thrombocytopenia, autoimmune hemolytic anemia, and neutropenia.

    Main Results:

    • Splenectomy was performed in 16 SLE patients, primarily for steroid-resistant thrombocytopenia (12 patients).
    • Excellent long-term outcomes were observed in 67% of patients with thrombocytopenia post-splenectomy.
    • Splenectomy corrected autoimmune hemolytic anemia in 67% of affected patients and benefited one patient with severe neutropenia and recurrent infections.

    Conclusions:

    • Splenectomy is a valuable therapeutic option for selected SLE patients suffering from autoimmune or hypersplenic cytopenias.
    • The procedure demonstrated significant long-term efficacy in managing refractory thrombocytopenia and autoimmune hemolytic anemia.
    • Splenectomy did not adversely affect other SLE manifestations, including renal function.

    Related Experiment Videos